The Surfaceome pp 127-149 | Cite as

Immunophenotyping of Live Human Pluripotent Stem Cells by Flow Cytometry

Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1722)

Abstract

Human pluripotent stem cells (hPSCs) have great potential for use in regenerative medicine and cell replacement therapies; however, prior to clinical application, cultured cell populations need to be screened to ensure the quality of the culture, as well as the capacity of these pluripotent cells to differentiate into desired cell types. Flow cytometry, utilizing antibodies recognizing targets restricted to the hPSC surfaceome, offers an invaluable tool for high-throughput validation of hPSC lines. Here we describe the immunophenotyping of live human embryonic stem cell (hESC, H9) and human induced pluripotent stem cell (hiPSC, KB3) lines by flow cytometry using a panel of antibodies identified as either stem cell reference markers (CD90, EpCam) or reported as being prevalent or restricted (c-Kit, HPI-1, Integrin α6, Semaphorin-6A) to these cells. The protocols described here with hPSCs are also applicable to differentiated hPSC progeny and should be instrumental in the immunophenotyping and isolation of well-defined homogeneous cell populations useful in regenerative medicine.

Key words

Embryonic stem cells Induced pluripotent stem cells Surfaceome Immunophenotyping Flow cytometry Antibody 

Notes

Acknowledgments

This research was supported by the Intramural Research Program of the NIH, National Institute on Aging, by the Research Grants Council of Hong Kong Theme-based Research Scheme T13-706/11, and the Hong Kong Research Grant Committee General Research Fund (Project number 17100214). We thank Robert Wersto and the NIA FC Core Facility for assistance with flow cytometry.

References

  1. 1.
    Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM (1998) Embryonic stem cell lines derived from human blastocysts. Science 282:1145–1147CrossRefPubMedGoogle Scholar
  2. 2.
    Tachibana M, Amato P, Sparman M, Gutierrez NM, Tippner-Hedges R, Ma H, Kang E, Fulati A, Lee HS, Sritanaudomchai H et al (2013) Human embryonic stem cells derived by somatic cell nuclear transfer. Cell 153:1228–1238CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861–872CrossRefPubMedGoogle Scholar
  4. 4.
    Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, Daley GQ (2008) Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451:141–146CrossRefPubMedGoogle Scholar
  5. 5.
    Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R et al (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917–1920CrossRefPubMedGoogle Scholar
  6. 6.
    Narsinh KH, Plews J, Wu JC (2011) Comparison of human induced pluripotent and embryonic stem cells: fraternal or identical twins? Mol Ther 19:635–638CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Ghosh Z, Wilson KD, Wu Y, Hu S, Quertermous T, Wu JC (2010) Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells. PLoS One 5:e8975CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Chin MH, Mason MJ, Xie W, Volinia S, Singer M, Peterson C, Ambartsumyan G, Aimiuwu O, Richter L, Zhang J et al (2009) Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5:111–123CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Narsinh KH, Sun N, Sanchez-Freire V, Lee AS, Almeida P, Hu S, Jan T, Wilson KD, Leong D, Rosenberg J et al (2011) Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells. J Clin Invest 121:1217–1221CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Tang C, Lee AS, Volkmer JP, Sahoo D, Nag D, Mosley AR, Inlay MA, Ardehali R, Chavez SL, Pera RR et al (2011) An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells. Nat Biotechnol 29:829–834CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Boheler KR, Bhattacharya S, Kropp EM, Chuppa S, Riordon DR, Bausch-Fluck D, Burridge PW, Wu JC, Wersto RP, Chan GC et al (2014) A human pluripotent stem cell surface N-glycoproteome resource reveals markers, extracellular epitopes, and drug targets. Stem Cell Rep 3:185–203CrossRefGoogle Scholar
  12. 12.
    Koivuniemi R, Makela J, Hokkanen ME, Bruelle C, Ho TH, Ola R, Korhonen L, Schroder J, Kataoka H, Lindholm D (2013) Hepatocyte growth factor activator inhibitor-1 is induced by bone morphogenetic proteins and regulates proliferation and cell fate of neural progenitor cells. PLoS One 8:e56117CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    van Galen P, Kreso A, Mbong N, Kent DG, Fitzmaurice T, Chambers JE, Xie S, Laurenti E, Hermans K, Eppert K et al (2014) The unfolded protein response governs integrity of the haematopoietic stem-cell pool during stress. Nature 510:268–272CrossRefPubMedGoogle Scholar
  14. 14.
    Yu KR, Yang SR, Jung JW, Kim H, Ko K, Han DW, Park SB, Choi SW, Kang SK, Scholer H et al (2012) CD49f enhances multipotency and maintains stemness through the direct regulation of OCT4 and SOX2. Stem Cells 30:876–887CrossRefPubMedGoogle Scholar
  15. 15.
    Chen G, Gulbranson DR, Hou Z, Bolin JM, Ruotti V, Probasco MD, Smuga-Otto K, Howden SE, Diol NR, Propson NE et al (2011) Chemically defined conditions for human iPSC derivation and culture. Nat Methods 8:424–429CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Beers J, Gulbranson DR, George N, Siniscalchi LI, Jones J, Thomson JA, Chen G (2012) Passaging and colony expansion of human pluripotent stem cells by enzyme-free dissociation in chemically defined culture conditions. Nat Protoc 7:2029–2040CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2018

Authors and Affiliations

  1. 1.Laboratory of Cardiovascular SciencesNational Institute on Aging, National Institutes of HealthBaltimoreUSA
  2. 2.School of Biomedical Sciences, LKS Faculty of MedicineThe University of Hong KongHong KongChina
  3. 3.Stem Cell & Regenerative Medicine Consortium, School of Biomedical Sciences, LKS Faculty of MedicineThe University of Hong KongHong KongChina

Personalised recommendations